UBS cut it’s target on XOM to $100 from $105 but keeps its buy rating.
This entry was posted
on Friday, August 1st, 2008 at 9:29 am and is filed under Equities.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.